Evidence text
Paper-level observation
These results indicate that sP10 did not cause significant pathological changes in the structure and function of the major organs of mice, suggesting that sP10 has good safety (Fig. 8).
figureConfidence: medium
Assay observation
Source publication
Peptide aptamer sP10 targeting NPM1 attenuates liver fibrosis and hepatocellular carcinoma.
Journal of Translational Medicine · 2026
Related peptide identities
Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.
